Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis.
Carrión B, Liu Y, Hadi M, Lundstrom J, Christensen JR, Ammitzbøll C, Dziegiel MH, Sørensen PS, Comabella M, Montalban X, Sellebjerg F, Issazadeh-Navikas S. Carrión B, et al. Among authors: ammitzboll c. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 12;8(6):e1065. doi: 10.1212/NXI.0000000000001065. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34385365 Free PMC article.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
Ratzer R, Iversen P, Börnsen L, Dyrby TB, Romme Christensen J, Ammitzbøll C, Madsen CG, Garde E, Lyksborg M, Andersen B, Hyldstrup L, Sørensen PS, Siebner HR, Sellebjerg F. Ratzer R, et al. Among authors: ammitzboll c. Mult Scler. 2016 Jun;22(7):926-34. doi: 10.1177/1352458515605908. Epub 2015 Oct 2. Mult Scler. 2016. PMID: 26432857 Clinical Trial.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Vinther-Jensen T, Börnsen L, Budtz-Jørgensen E, Ammitzbøll C, Larsen IU, Hjermind LE, Sellebjerg F, Nielsen JE. Vinther-Jensen T, et al. Among authors: ammitzboll c. Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e287. doi: 10.1212/NXI.0000000000000287. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27734023 Free PMC article.
Defining active progressive multiple sclerosis.
Sellebjerg F, Börnsen L, Ammitzbøll C, Nielsen JE, Vinther-Jensen T, Hjermind LE, von Essen M, Ratzer RL, Soelberg Sørensen P, Romme Christensen J. Sellebjerg F, et al. Among authors: ammitzboll c. Mult Scler. 2017 Nov;23(13):1727-1735. doi: 10.1177/1352458517726592. Epub 2017 Aug 23. Mult Scler. 2017. PMID: 28831853
Disability in progressive MS is associated with T2 lesion changes.
Ammitzbøll C, Dyrby TB, Lyksborg M, Schreiber K, Ratzer R, Romme Christensen J, Iversen P, Magyari M, Garde E, Sørensen PS, Siebner HR, Sellebjerg F. Ammitzbøll C, et al. Mult Scler Relat Disord. 2018 Feb;20:73-77. doi: 10.1016/j.msard.2017.12.010. Epub 2017 Dec 18. Mult Scler Relat Disord. 2018. PMID: 29324249 Clinical Trial.
Progressive multiple sclerosis, cognitive function, and quality of life.
Højsgaard Chow H, Schreiber K, Magyari M, Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Soelberg Sørensen P, Sellebjerg F. Højsgaard Chow H, et al. Among authors: ammitzboll c. Brain Behav. 2018 Jan 5;8(2):e00875. doi: 10.1002/brb3.875. eCollection 2018 Feb. Brain Behav. 2018. PMID: 29484253 Free PMC article.
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
von Essen MR, Ammitzbøll C, Hansen RH, Petersen ERS, McWilliam O, Marquart HV, Damm P, Sellebjerg F. von Essen MR, et al. Among authors: ammitzboll c. Brain. 2019 Jan 1;142(1):120-132. doi: 10.1093/brain/awy301. Brain. 2019. PMID: 30561509 Clinical Trial.
42 results